Allworth Financial
JBIO icon

Allworth Financial’s Jade Biosciences JBIO Stock Holding History

Allworth Financial’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31K Buy
149
+49
+49% +$1.02K ﹤0.01% 4313
2026
Q1 		$1.41K Buy
100
+76
+317% +$1.1K ﹤0.01% 4464
2025
Q4 		$371 Buy
+24
New +$282 ﹤0.01% 4596

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jupiter Topco
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Bellevue Group
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allworth Financial's JBIO Position: Q2 2026 in Review

Allworth Financial increased its Jade Biosciences (JBIO) stake by 49% in Q2 2026, buying an estimated $1.02K and bringing the position to 149 shares worth $3.31K. The position accounts for ﹤0.01% of the portfolio, ranked #4313.

Allworth Financial first reported a position in JBIO in Q4 2025 and has held it in 3 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Allworth Financial held 149 shares of Jade Biosciences worth $3.31K as of Q2 2026.
  • Allworth Financial bought 49 Jade Biosciences shares in Q2 2026, an estimated $1.02K.
  • Jade Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #4313 holding.
  • Allworth Financial first reported a position in Jade Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.